MedPath

Leucine Supplementation and Skeletal Muscle Disuse

Not Applicable
Completed
Conditions
Disuse Atrophy
Interventions
Dietary Supplement: Leucine
Dietary Supplement: Placebo
Registration Number
NCT01192009
Lead Sponsor
University of Sao Paulo
Brief Summary

Leucine supplementation is widely known for promoting strong influence on skeletal muscle remodeling. This study aims to evaluate the effect of leucine supplementation on disuse-induced skeletal muscle atrophy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
22
Inclusion Criteria
  • Clinical diagnosis of anterior cruciate ligament injury
  • Physically active
  • Must be able to swallow tablets
  • Non-smokers
  • Do not use nutritional supplements
Read More
Exclusion Criteria
  • Post-surgical complications
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Immobilization and LeucineLeucine-
Immobilization and PlaceboPlacebo-
Primary Outcome Measures
NameTimeMethod
Skeletal muscle structure (cross-sectional area)2 weeks
Secondary Outcome Measures
NameTimeMethod
Molecular signalling pathways (hypertrophy, atrophy, and inflammation)2 weeks

Trial Locations

Locations (1)

University of São Paulo - School of Physical Education and Sports

🇧🇷

São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath